Gabriel Kaigham, a director at Trimble Inc., has sold 2,476 shares of the company's common stock, valued at approximately $160,940. This transaction, reported in a recent SEC filing, illustrates the ongoing activity of corporate insiders in the measuring and controlling devices sector.
Kaigham's sale occurred on October 29, 2026, and is part of a broader trend where executives manage their stock holdings, often in conjunction with compensation packages. The shares were acquired through restricted stock vesting, which took place on May 30, 2025.
Background
Trimble Inc. is a company focused on providing advanced positioning solutions and software for various industries, including agriculture, construction, and transportation. The company is classified under the SIC code for measuring and controlling devices, specifically in the industrial applications and services sector. Trimble is publicly traded on the NASDAQ, with a central index key of 0000864749.
What the Filing Says
"Gabriel Kaigham sold 2,476 shares of common stock valued at approximately $160,940."
The SEC filing, accession number 0001959173-26-007546, details the sale and includes information about the acquisition of the shares, which were granted as part of Kaigham's compensation package. The filing also notes that Kaigham sold 1,718 shares earlier this year on August 4, 2026, for gross proceeds of $103,080.
Impact
This transaction may affect shareholders and potential investors by highlighting the actions of insiders at Trimble Inc. It also raises questions about the timing and motivations behind such sales, which can influence market perceptions of the company's future performance. The ongoing insider trading activity could indicate confidence or concern regarding the company's stock performance among its executives.
What's Next
The filing does not say what happens next.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










